Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,046,496
-
Share change
-
+3,154,332
-
Total reported value
-
$287,166,288
-
Put/Call ratio
-
54%
-
Price per share
-
$12.49
-
Number of holders
-
102
-
Value change
-
+$45,258,695
-
Number of buys
-
64
-
Number of sells
-
33
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q3 2022
As of 30 Sep 2022,
G1 THERAPEUTICS INC - COM (GTHX) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,046,496 shares.
The largest 10 holders included
Fisher Asset Management, LLC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Paradigm Biocapital Advisors LP, BIOIMPACT CAPITAL LLC, MARSHALL WACE, LLP, and FMR LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.